Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federica Begalli

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Best Practice & Research. Clinical Endocrinology & Metabolism|April 23, 2026
Genetic endocrine tumours focusing on pituitary tumoursErik Bényei, Federica Begalli, Márta Korbonits
Biomedicines|August 23, 2017
Unlocking the NF-κB Conundrum: Embracing Complexity to Achieve SpecificityFederica Begalli, Jason Bennett, Daria Capece, et al.
The International Journal of Biochemistry & Cell Biology|December 27, 2017
NF-κB in the crosshairs: Rethinking an old riddleJason Bennett, Daria Capece, Federica Begalli, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 8, 2021
Extracellular Flux Analysis to Investigate the Impact of NF-κB on Mitochondrial Respiration in Colorectal Carcinoma (CRC)Daria Capece, Daniela Verzella, Federica Begalli, et al.
Stem Cells International|March 17, 2017
<i>β</i>-Arrestin1/miR-326 Transcription Unit Is Epigenetically Regulated in Neural Stem Cells Where It Controls Stemness and Growth ArrestAgnese Po, Federica Begalli, Luana Abballe, et al.
The EMBO Journal|October 1, 2013
microRNA-17-92 cluster is a direct Nanog target and controls neural stem cell through Trp53inp1Neha Garg, Agnese Po, Evelina Miele, et al.
Neuro-Oncology|December 6, 2013
High-throughput microRNA profiling of pediatric high-grade gliomasEvelina Miele, Francesca Romana Buttarelli, Antonella Arcella, et al.
BMC Cancer|July 19, 2017
β-arrestin1-mediated acetylation of Gli1 regulates Hedgehog/Gli signaling and modulates self-renewal of SHH medulloblastoma cancer stem cellsEvelina Miele, Agnese Po, Federica Begalli, et al.
Cancer Research|December 28, 2017
GADD45β Loss Ablates Innate Immunosuppression in CancerDaniela Verzella, Jason Bennett, Mariafausta Fischietti, et al.
Toxicology Reports|May 14, 2019
Preclinical toxicology and safety pharmacology of the first-in-class GADD45β/MKK7 inhibitor and clinical candidate, DTP3Laura Tornatore, Daria Capece, Daniel D'Andrea, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Best Practice & Research. Clinical Endocrinology & Metabolism|April 23, 2026
Genetic endocrine tumours focusing on pituitary tumoursErik Bényei, Federica Begalli, Márta Korbonits
Biomedicines|August 23, 2017
Unlocking the NF-κB Conundrum: Embracing Complexity to Achieve SpecificityFederica Begalli, Jason Bennett, Daria Capece, et al.
The International Journal of Biochemistry & Cell Biology|December 27, 2017
NF-κB in the crosshairs: Rethinking an old riddleJason Bennett, Daria Capece, Federica Begalli, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 8, 2021
Extracellular Flux Analysis to Investigate the Impact of NF-κB on Mitochondrial Respiration in Colorectal Carcinoma (CRC)Daria Capece, Daniela Verzella, Federica Begalli, et al.
Stem Cells International|March 17, 2017
<i>β</i>-Arrestin1/miR-326 Transcription Unit Is Epigenetically Regulated in Neural Stem Cells Where It Controls Stemness and Growth ArrestAgnese Po, Federica Begalli, Luana Abballe, et al.
The EMBO Journal|October 1, 2013
microRNA-17-92 cluster is a direct Nanog target and controls neural stem cell through Trp53inp1Neha Garg, Agnese Po, Evelina Miele, et al.
Neuro-Oncology|December 6, 2013
High-throughput microRNA profiling of pediatric high-grade gliomasEvelina Miele, Francesca Romana Buttarelli, Antonella Arcella, et al.
BMC Cancer|July 19, 2017
β-arrestin1-mediated acetylation of Gli1 regulates Hedgehog/Gli signaling and modulates self-renewal of SHH medulloblastoma cancer stem cellsEvelina Miele, Agnese Po, Federica Begalli, et al.
Cancer Research|December 28, 2017
GADD45β Loss Ablates Innate Immunosuppression in CancerDaniela Verzella, Jason Bennett, Mariafausta Fischietti, et al.
Toxicology Reports|May 14, 2019
Preclinical toxicology and safety pharmacology of the first-in-class GADD45β/MKK7 inhibitor and clinical candidate, DTP3Laura Tornatore, Daria Capece, Daniel D'Andrea, et al.
Pageof 2